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https://doi.org/10.1016/j.stemcr.2019.10.004SUMMARYCADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) is the most common form of
genetic stroke and vascular dementia syndrome resulting from mutations in NOTCH3. To elucidate molecular mechanisms of the con-
dition and identify drug targets, we established a patient-specific induced pluripotent stem cell (iPSC) model and demonstrated for the
first time a failure of the patient iPSC-derived vascular mural cells (iPSC-MCs) in engaging and stabilizing endothelial capillary structures.
The patient iPSC-MCs had reduced platelet-derived growth factor receptor b, decreased secretion of the angiogenic factor vascular endo-
thelial growth factor (VEGF), were highly susceptible to apoptotic insults, and could induce apoptosis of adjacent endothelial cells. Sup-
plementation of VEGF significantly rescued the capillary destabilization. Small interfering RNA knockdown of NOTCH3 in iPSC-MCs
revealed a gain-of-function mechanism for the mutant NOTCH3. These disease mechanisms likely delay brain repair after stroke in
CADASIL, contributing to the brain hypoperfusion and dementia in this condition, and will help to identify potential drug targets.INTRODUCTION
CADASIL (cerebral autosomal dominant arteriopathy with
subcortical infarcts and leukoencephalopathy), a systemic
small vessel disease (Joutel et al., 1996, 1997; Sharma
et al., 2001; Wang et al., 2008), is the most common type
of genetic stroke syndrome and vascular dementia.
Although clinical presentations are diverse (Bentley et al.,
2011) and disease severity varies among patients, the un-
derlying pathologies are unique in small arteries, including
degeneration of vascular smooth muscle cells (VSMCs),
accumulation of NOTCH3 extracellular domain proteins
(N3ECD), and deposition of granular osmiophilic material
(Joutel et al., 2000). Valuable insights into disease pathol-
ogies have been uncovered using animal or cell models
(Joutel et al., 2000); however, the molecular mechanisms
underpinning the condition are still largely unknown,
and thus no effective treatment is available. The majority
of the CADASIL NOTCH3 mutations do not disrupt
canonical NOTCH3 signaling (Monet et al., 2007), and
Notch3/ mice do not develop the CADASIL phenotype
(Domenga et al., 2004); therefore, this condition does not
seem to be caused by a simple loss of NOTCH3 function.
Notch proteins are single-pass transmembrane receptors
mediating an evolutionarily conserved signaling pathway
(Artavanis-Tsakonas et al., 1999). Ligand binding triggersStem Cel
This is an open access article under the Csequential Notch protein cleavages that release the intra-
cellular domain (NICD). The NICD then translocates into
the nucleus, where it activates the canonical Notch
signaling pathway, regulating the expression of Notch
target genes including hairy and enhancer of split (HES)
andHairy-related transcription factor (HRT/HEY).NOTCH3
is specifically expressed in the arterial smooth muscle cells
(SMCs) and pericytes, collectively called mural cells (MCs),
and supports VSMC differentiation and MC survival (Jou-
tel, 2011; Wang et al., 2012, 2014). However, a full picture
of NOTCH3 function in MCs is still unclear.
In addition to VSMC pathology, abnormal endothelial
cells (ECs) and impaired shear stress-induced or endothe-
lium-dependent vasodilatation were also observed in small
arteries of CADASIL patients (Dubroca et al., 2005; Sten-
borg et al., 2007). NOTCH3 expression is usually very low
or absent in ECs, which brings into question the primary
involvement of ECs in CADASIL pathology. In intact ar-
teries, a positive feedback loop exists between the Notch
ligand Jagged1 in ECs and NOTCH3 in the adjacent
VSMCs, which is fundamental for both arterial develop-
ment and the functional maintenance of mature arteries
(Liu et al., 2009, 2010). The EC-MC communication via
Notch signaling is likely perturbed by the NOTCH3 muta-
tion in CADASIL. However, this has never been demon-
strated experimentally. Recent data revealed a substantiall Reports j Vol. 13 j 1–15 j November 12, 2019 j ª 2019 The Author(s). 1
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CADASIL mice resulting in hypoperfusion in the brain
(Joutel et al., 2010), which suggests an angiogenesis-related
failure. Pericytes, the perivascular cells surrounding capil-
laries, play a key role in the process of angiogenesis, sup-
porting capillary stability and EC survival (Sweeney et al.,
2016). Interestingly, the NOTCH3 signaling pathway has
recently been identified to be crucial in regulating pericyte
number and for proper angiogenesis and MC investment
(Liu et al., 2010;Wang et al., 2014). However, to our knowl-
edge, the impact of NOTCH3mutation on angiogenesis in
CADASIL has never been investigated previously.
To date, up to ten transgenic CADASIL mouse models
have been generated. Although recent models appear
much improved (Joutel, 2011; Wallays et al., 2011), the
CADASIL mice did not phenocopy the full spectrum of
clinical features seen in CADASIL patients, especially the
brain pathologies. Previous cell-based CADASIL studies
have mainly used overexpression of mutant NOTCH3 in
non-vascular cell lines (Bentley et al., 2011; Joutel et al.,
2004; Peters et al., 2004). Given the fact that the Notch
signaling is highly dosage and context dependent, the
strategy of overexpression may not faithfully reflect the
true pathological defects in the vascular cells of CADASIL
patients.
It is now possible to generate patient-specific disease
models without overexpressing mutant gene products.
By co-transfecting key pluripotency-associated factors
(OCT3/4, SOX2, C-MYC, and KLF4), adult somatic cells
can be reprogrammed to induced pluripotent stem cells
(iPSCs) that have potential to differentiate into cells from
all three embryonic germ layers (Takahashi and Yamanaka,
2006). iPSC-derived cells carry the genetic information of
the donor and therefore represent patient-specific disease
models to be used for elucidating disease mechanisms
and for in vitro high-throughput drug screening (Tiscornia
et al., 2011).
In this study, we have successfully established iPSCs from
CADASIL patients. The iPSCs were differentiated into ECs
and MCs. Phenotypic characterization of the iPSC disease
model identified failure of the iPSC-derived MCs (iPSC-
MCs) to stabilize angiogenic capillary structures and sup-
port iPSC-derived EC (iPSC-EC) survival, suggesting a
defect of pericyte function. The CADASIL iPSC-MCs had
downregulation of PDGFRb (platelet-derived growth factor
receptor b) and reduced secretion of vascular endothelial
growth factor (VEGF). Supplement of VEGF or small inter-
fering RNA (siRNA) knockdown of NOTCH3 significantly
rescued the phenotypes. Key findings obtained from the
iPSC model were also confirmed on primary VSMCs iso-
lated from CADASIL patients. The novel molecular mecha-
nisms uncovered by using the new patient-specific iPSC
model could advance our knowledge of this genetic condi-2 Stem Cell Reports j Vol. 13 j 1–15 j November 12, 2019tion and vascular dementia in general, and contribute to
the future development of novel therapies.RESULTS
Generation of Disease-Specific iPSC Lines
Human dermal fibroblasts (HDFs) were obtained from skin
biopsies of two CADASIL patients carrying the mutations
Arg153Cys and Cys224Tyr (Figures S1A and S1B), respec-
tively, and two control individuals (Figures S1C and S1D).
One of the control individuals was an unaffected sibling of
the patient who carries the Cys224Tyr mutation. The HDFs
were transformed into iPSCs by Sendai virus (SeV) delivery
of transcription factorsOCT4, SOX2, KLF4, and C-MYC (Fig-
ure S2A). Twenty-eight days after virus infection, multiple
colonies (12–18 clones from each line) were selected and
expanded, and theexpressionof thepluripotency-associated
genes,OCT4, SOX2, andNANOG,was confirmed inthe iPSCs
(Figure S2B). A subset of clones was karyotyped (Figure S2C)
and screened for residual SeV carried over from the initial
infection. All selected clones were free of SeV after ten pas-
sages (Figure S2D). The reprogrammed cells were able to
form embryoid bodies, which expressed ectoderm, meso-
derm, and endodermmarker genes (Figure S2E), confirming
the pluripotency of the cells. Thus, we established two pa-
tient-specific iPSC lines and two control iPSC lines. Based
on the characterization described above, three clones from
each iPSC line with normal karyotypes were randomly cho-
sen for the subsequent work.Differentiation of iPSCs into ECs and MCs
ECs andMCs, the twomajor vascular cell types, were differ-
entiated from the healthy and CADASIL iPSCs. For EC dif-
ferentiation, iPSCs were treated with a combination of
growth factors for 12 days as shown schematically in Fig-
ure 1A. On day 3, monolayers of broader cells with a
cobblestone appearance started to emerge from the edges
of the tightly packed colonies. After bone morphogenetic
protein (BMP) withdrawal and addition of VEGF on day 6
to promote EC differentiation, the cobblestone-like cells
expanded and persisted through the course of differentia-
tion (Figure 1B). Over the 12-day differentiation period,
the expression of pluripotency-associated genes (OCT4,
SOX-2, and NANOG) decreased progressively (Figure 1C).
On day 3 after increased dosage of BMP4, a transient
expression of the T gene was observed, indicating early
mesoderm commitment. This was followed by an increase
in additional mesoderm markers, ISL1 and MESP1, which
peaked on day 6. After addition of VEGF on day 6, the
endothelial specific markers, VE-CADHERIN and PECAM-
1/CD31, as well as KDR, were significantly induced and
reached a plateau by day 12 of differentiation.
Figure 1. Endothelial Cell Differentiation from iPSCs
(A) Schematic illustration of EC differentiation protocol.
(B) Morphological changes of iPSCs during EC differentiation.
(legend continued on next page)
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subjected to cell sorting using a VE-cadherin antibody,
which revealed the differentiation efficiency to be 37%–
45% (Figure 1D). After sorting, a pure population of ECs
was obtained and grew healthily after reseeding with
expression of endothelial specific marker proteins
PECAM-1 and VE-cadherin (Figure 1E).
Functional characterization of the iPSC-ECs showed that
the cells progressively gained an ability to produce nitric
oxide in response to carbachol treatment during the course
of differentiation (Figure 1F). The iPSC-ECs had the ability
to form tube-like structures on a Matrigel substrate similar
to bona fide endothelial cells, suggesting the generation of
functional ECs from iPSCs (Figure 1G).
For MC differentiation, a protocol generating a neuro-
ectoderm intermediate was adopted (Cheung et al.,
2012) (Figure 2A) to obtain iPSC-MCs with a phenotype
resembling more closely the neural crest-derived MCs in
the cerebral arteries where CADASIL pathologies are
mainly manifest. In the presence of fibroblast growth fac-
tor 2 (FGF2) and the inhibition of transforming growth
factor b (TGF-b) type I receptor by SB-431542 for
6–7 days, the iPSCs changed to a bipolar morphology
with increased SOX2 expression and positive SOX1 and
Nestin staining. This indicated the production of neural
progenitor cells (Figures 2B and 2C). The growth factors
were then switched to platelet-derived growth factor BB
(PDGF-BB) and TGF-b to specifically promote MC differ-
entiation until day 18 when the cells had adopted a
mesenchymal cell-like morphology with significantly
increased expression of the SMC markers a-SMA, CNN1,
and SM22a (Figures 2B and 2D), and SMMHC or SMTN
(Figure S3).
During EC and MC differentiation, no significant differ-
encewas observed between the CADASIL and control iPSCs
for the expressions of marker genes tested (Figures 1C
and 2B). The expression of NOTCH3, NOTCH1, 2, and 4,
NOTCH ligand JAG1, and NOTCH target genes HES1,
HES2, and HEYL were also not changed in the CADASIL
iPSC-MCs (Figure S3). This suggests that NOTCH3 muta-
tions are unlikely to significantly affect the differentiation(C) qRT-PCR showing changes of gene-expression profiles for pluripot
endothelial (KDR, PECAM-1, VE-CADHERIN) marker genes relative to G
(D) Example of fluorescence-activated cell sorting (FACS) for VE-cadh
(E) Immunofluorescence staining of VE-cadherin+ iPSC-ECs reseeded a
(F) Nitric oxide production from iPSC-ECs over the course of iPSC-EC
arterial endothelial cells (hCAECs).
(G) In vitro angiogenesis assay in Matrigel showing that iPSC-ECs are
total network length as shown in (b) using ImageJ software.
Data in (C) and (F) are mean ± SEM of three independent experiments (
CADASIL or control line. Two-way ANOVA with Tukey’s post hoc test, *
found between CADASIL and controls. Scale bars, 100 mm.
4 Stem Cell Reports j Vol. 13 j 1–15 j November 12, 2019of ECs or MCs from iPSCs, or the canonical Notch
signaling.
CADASIL MCs Fail to Stabilize Endothelial Capillary
Tubule Structure
To address the brain hypoperfusion pathology seen in
CADASIL patients, we performed in vitro Matrigel-assisted
angiogenic network formation using the iPSC-derived
vascular cells. When using the iPSC-ECs alone, networks
emerged at 6 h after cell seeding, peaked at 24 h, and grad-
ually disassembled and disappeared by 72 h (Figure 3A),
representing a typical time course of in vitro angiogenesis
on Matrigel. There was no significant difference between
the CADASIL and control iPSC-ECs in their ability to
form networks (Figure 3A), suggesting that the CADASIL
NOTCH3 mutations are unlikely to interfere with de novo
angiogenesis of ECs. When the control iPSC-MCs were
included in the angiogenesis assay, the network structure
was significantly stabilized for up to 72 h, reflecting the
normal function of MCs in stabilizing capillary structures
(Figure 3B). However, when the iPSC-MCs from CADASIL
patients were included in the assay, they significantly failed
to stabilize the endothelial network (Figure 3B). This obser-
vation strongly suggests an intrinsic defect of CADASIL
iPSC-MCs.
To confirm the results, we co-cultured CADASIL iPSC-
MCs with the control iPSC-ECs and vice versa. Similarly,
the CADASIL iPSC-MCs were unable to stabilize the net-
works formed by the control iPSC-ECs whereas the control
iPSC-MCs were able to stabilize the CADASIL iPSC-EC net-
works (Figure 3C), further suggesting a primary defect of
the CADASIL iPSC-MCs.
Accordingly, immunofluorescent imaging showed a clear
loss of CADASIL iPSC-MCs from the tubular structures at
24 h after cell seeding, and total disappearance of the
iPSC-MCs from the EC network at 48 h (Figure 3D).
To further confirm these results, we used primary SMCs
that were isolated from a CADASIL patient and conducted
similar in vitro angiogenesis assays. In line with findings
from the iPSC-MCs, the primary SMCs showed a significant
defect in stabilizing the EC networks (Figure S4).ent (OCT4, SOX2, NANOG), mesodermal (T, ISL-1, MESP1, KDR), and
APDH during the course of iPSC-MC differentiation.
erin+ iPSC-ECs at day 12 of differentiation.
fter FACS. PECAM-1, green; VE-cadherin, red.
differentiation compared with that from primary human coronary
able to form capillary tubular networks (a) that are quantifiable for
n = 3). Each experiment contained samples from three clones of each
p% 0.05, **p% 0.01, ***p% 0.001, versus day 0; no differences
Figure 2. Mural Cell Differentiation from iPSCs through a Neuroectodermal Intermediate
(A) Schematic illustration of MC differentiation protocol.
(B) qRT-PCR determination of gene-expression profiles for the pluripotent (OCT3/4), neuroectodermal (SOX-1, SOX-2), and smooth
muscle/MC (SM22a, CNN1, a-SMA) markers during iPSC-MC differentiation. Data are mean ± SEM of three independent experiments (n = 3).
Each experiment contained samples from three clones of each CADASIL or control line. There were no differences found between CADASIL
and controls. Two-way ANOVA tests was followed by Tukey’s post hoc test in (B). *p% 0.05, **p% 0.01, ***p% 0.001 versus day 0.
Scale bars, 200 mm (C) and 100 mm (D).
(C) Immunofluorescence staining for neural stem cell marker Nestin (green) and Sox-1 (red) at day 6 of the iPSC-MC differentiation with
DAPI nuclear counterstain (blue).
(D) Immunofluorescence staining for SMCmarkers calponin (green), SM22a (red), and a-SMA (green) at day 18 of differentiation with DAPI
counterstaining (blue).
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the angiogenic tubule structure had significantly disinte-
grated and cells formed aggregates in assays that contained
CADASIL SMCs (Figure S4B).
An in vivo angiogenesis assay in SCID mice was also car-
ried out, by subcutaneous injection of a mixture of the
iPSC-ECs and iPSC-MCs from the patient or control with
Matrigel. Twoweeks after implantation, network structures
were formed, mainly by the human iPSC-derived vascular
cells, as evidenced by the human-specific mitochondrial
antibody staining (Figure S5A). In linewith the in vitro find-ings above, the patient iPSC-MCs (calponin+) were
extremely sparse in the network structure within theMatri-
gel plugs (Figures S5Ba, S5Bb, S5Be, and S5Bf). In contrast,
control iPSC-MCs were still abundant in the network (Fig-
ures S5Bc, S5Bd, S5Bg, and S5Bh), suggesting lack of sup-
port of the in vivo capillary tubules by CADASIL MCs.
Notably, apart from a thin capsule layer formed around
the plugs, as indicated by the dense band of DAPI-stained
cells lacking anti-human mitochondrial signals, there was
no significant host vascular cell invasion into the Matrigel
plugs within 2 weeks of implantation (Figure S5A).Stem Cell Reports j Vol. 13 j 1–15 j November 12, 2019 5
Figure 3. In Vitro Angiogenesis Analysis
of iPSC-Derived Endothelial Cells and
Mural Cells
iPSC-derived ECs and MCs were cultured in
Matrigel for in vitro assay of capillary tubule
network formation.
(A) In vitro tubule formation by iPSC-ECs
alone. CADASIL samples from two patients
are in red and orange, respectively; control
samples from two individuals are in blue and
green, respectively.
(B) iPSC-ECs co-culture with iPSC-MCs.
Result showing CADASIL iPSC-MCs failed to
support stability of the tubule structure
compared with the controls in the iPSC-
EC/MC co-culture.
(C) In vitro tubule formation by iPSC-EC/MC
co-culture in different combinations of
CADASIL and control iPSC-ECs and iPSC-MCs.
CADASIL iPSC-MCs had impaired ability to
support the tubule stability formed by either
CADASIL or control iPSC-ECs (warm colored
lines) while the control iPSC-MCs were able
to stabilize the tubule structure (cold
colored lines).
(D) Immunofluorescence staining of the
tubular structures formed by iPSC-EC/MC co-
culture showing failure of CADASIL iPSC-MCs
(a-SMA, green) to engage with iPSC-ECs
(CD31, red) from 24 h onward during the
angiogenesis assay.
Data in (A) to (C) are presented as mean ±
SEM of three independent experiments
(n = 3). Each experiment contained samples
from three clones of each CADASIL or three
clones of each control line. Two-way ANOVA
with Tukey’s post hoc test, ***p < 0.001.
Scale bars, 50 mm.
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The capillary stability is usually supported by pericytes.
This cell type is difficult to distinguish from VSMCs based
on marker gene expression alone, but can generally be
identified by their ability in supporting capillary structures,
and their location and morphology (van Dijk et al., 2015).
The iPSC-MCs that we generated were associated with and
supported the capillary structures (Figures 3 and S6A), and
expressed a combination of commonly used pericyte
marker genes (PDGFRb, NG2, and a-SMA; Figure S6B), ful-
filling the current criteria for pericytes. Therefore, the
iPSC-MC-assisted angiogenesis could be used as a pericyte
model, and the defect of CADASIL iPSC-MCs in supporting
the EC network structure suggests a pericyte dysfunction in
CADASIL.
PDGFRb is known to play a key role in pericyte recruit-
ment by ECs and capillary structure maintenance during6 Stem Cell Reports j Vol. 13 j 1–15 j November 12, 2019angiogenesis (Ribatti et al., 2011). We therefore measured
PDGFRb level by qRT-PCR and western blotting, and found
significant reduction of PDGFRb in CADASIL iPSC-MCs
(Figures S6C and S6D). However, supplement of PDGF
was not able to extend the stability of the network formed
by iPSC-ECs alone (Figure S6E), suggesting that the pres-
ence of the actual PDGFRb-expressing pericytes is required.
Indeed, application of a PDGFR inhibitor did not affect
network formation by iPSC-ECs (Figure S6F), confirming
that PDGF is not essential for the tubule formation by
ECs alone. Additionally, the reduced capillary stabilizing ef-
fect by the PDGFRb-deficient CADASIL iPSC-MCs could
not be compensated by simply increasing the PDGFRb
ligand PDGF-BB in the EC-MC co-cultured angiogenesis
assay system; instead, PDGF-BB showed a detrimental ef-
fect on the tubule stability (Figure S6G), which could be
due to the pro-migration role of PDGF (Marmur et al.,
Figure 4. Apoptosis of iPSC-MCs, iPSC-
ECs, and Primary SMCs from CADASIL
and Control Individuals
(A and B) CADASIL and control iPSC-MCs (A)
and iPSC-ECs (B) were exposed to increasing
concentrations of staurosporine and
hydrogen peroxide for 24 h, and caspase-
3/7 activity was then determined by a
Promega Caspase-Glo 3/7 Assay Kit. Data are
presented as mean ± SEM of three inde-
pendent experiments (n = 3). Each experi-
ment contained samples from three clones
of each CADASIL or three clones of each
control line. Two-way ANOVA with Tukey’s
post hoc test, ***p% 0.001 versus control
samples.
(C) Primary SMCs isolated from small arteries
of four CADASIL patients and four control
individuals were exposed to increasing
concentrations of hydrogen peroxide for
24 h. Caspase-3/7 activity was determined
as mentioned above. Data are mean ± SEM,
n = 4/group. One-way ANOVA with Bonfer-
roni’s post hoc test, *p < 0.05 versus control
counterparts.
(D) Different combinations of CADASIL and
control iPSC-MCs and iPSC-ECs were co-
cultured for 24 h, and the iPSC-MCs and
iPSC-ECs were then separated by CD31
magnetic beads. Caspase-3/7 activity in the
separated iPSC-ECs was determined. Co-
cultures of either CADASIL or control iPSC-
ECs with CADASIL iPSC-MCs (red); co-culture
of either CADASIL or control iPSC-ECs with
control iPSC-MCs (blue). Data are mean ±
SEM of three independent experiments
(n = 3) for each patient or control iPSC lines
with three technical repeats for each sample
in each experiment. Student’s t test, ***p
% 0.001.
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CADASIL iPSC-MCs Are Sensitive to Apoptotic Insults
and Impair Adjacent EC Survival
The impaired engagement of CADASILMCswith ECs could
also be the result of reduced survival of the CADASIL MCs;
therefore, apoptosis was measured using a caspase assay.
Under basal states, caspase activity was similarly very low
in both CADASIL and control iPSC-MCs (Figure 4A). How-
ever, when the cells were challenged by the apoptotic in-
ducers staurosporine and hydrogen peroxide, a significantand dose-dependent increase in apoptosis was induced in
the CADASIL iPSC-MCs compared with the control (Fig-
ure 4A). In contrast, caspase activity was identical between
the iPSC-ECs from CADASIL patients and controls (Fig-
ure 4B), which excluded the likelihood of ECs being the
primary cause of capillary structure destabilization. The
increased sensitivity of CADASIL MCs to apoptotic chal-
lenge was further confirmed in primary VSMCs isolated
from CADASIL patients (Figure 4C).
Additionally, CADASIL iPSC-MCs exhibited detrimental
effects on the adjacent iPSC-ECs. When the iPSC-MCs
and iPSC-ECs were co-cultured for 24 h before beingStem Cell Reports j Vol. 13 j 1–15 j November 12, 2019 7
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beads and then subjected to caspase activity determina-
tion, the CADASIL iPSC-MCs significantly induced
apoptosis of the iPSC-ECs from both CADASIL and control
individuals, whereas the control iPSC-MCs did not have
such an effect on adjacent iPSC-ECs (Figure 4D).
CADASIL iPSC-MCs Have Reduced Secretion of VEGF
To determine whether soluble factors are involved in the
detrimental effect of CADASIL MCs on ECs, we applied
conditioned medium from iPSC-MC culture to the iPSC-
EC angiogenesis assay. The conditioned medium from
CADASIL iPSC-MCs significantly disrupted the angiogenic
tubule formation by either control or CADASIL iPSC-ECs
(Figures 5A and 5B), suggesting an abnormal secretion of
soluble paracrine factor(s) from the CADASIL iPSC-MCs.
This was further supported using a transwell co-culture sys-
tem in which the iPSC-MCs were grown on an insert
without direct contact with ECs (Figure 5C). Again the
EC-tubule structures collapsed significantly earlier when
the CADASIL iPSC-MCs rather than the control iPSC-MCs
were present (Figure 5C).
To identify the nature of the soluble factor(s) that were
abnormally secreted from the CADASIL iPSC-MCs, we
screened an angiogenesis antibody array. A significant
reduction in VEGF level was identified in the CADASIL
iPSC-MC culture medium (Figures 6A and S7), which was
confirmed by quantitative ELISA (Figure 6B) and qRT-PCR
on the CADASIL iPSC-MCs (Figure 6C). A trend of reduced
mRNA expression and secretion of VEGF was also
confirmed on the primary VSMCs that were isolated from
a CADASIL patient (Figures 6D and S7).
Supplementing with VEGF Significantly Rescues the
Stability of Endothelial Capillary Structures
VEGF is critically involved in angiogenesis. We demon-
strated that supplementation of VEGF could promote
angiogenesis for both control and CADASIL iPSC-ECs
(Figure S7D), and blocking VEGF receptors completely
abolished the angiogenesis (Figure S7E). We then supple-
mented VEGF to the iPSC-EC-MC co-culture angiogenesis
assay, which significantly stabilized the tubule structure
formed by iPSC-ECs and iPSC-SMCs from CADASIL pa-
tients for a further 48 h (Figure 7A). The exogenous
VEGF did not have detectable effects on the tubule
structure formed by the co-cultured control iPSC-ECs and
iPSC-MCs.
VEGF Secretion from CADASIL iPSC-MCs Was
Restored by siRNA Knockdown of NOTCH3
To clarify whether the CADASIL phenotype that we identi-
fied was caused by loss- or gain-of-function mutation of
NOTCH3, we used siRNA to knock down the NOTCH38 Stem Cell Reports j Vol. 13 j 1–15 j November 12, 2019transcript in the iPSC-MCs, which achieved 80% knock-
down efficiency (Figure 7C). When the NOTCH3-deficient
CADASIL iPSC-MCs were co-cultured with iPSC-ECs, the
tubule stabilizing ability was significantly restored (Fig-
ure 7B), similar to the extent of the VEGF rescue seen in Fig-
ure 7A. Accordingly, VEGF in the culture medium of the
CADASIL iPSC-MCs returned to the control level after
siRNA NOTCH3 knockdown (Figure 7D), suggesting a
gain-of-function phenotype by the mutant NOTCH3.
NOTCH3 knockdown by siRNA did not have a significant
impact on the tubule formation by the control iPSC-
derived ECs and SMCs.DISCUSSION
Using a patient-specific iPSC model, we demonstrated an
intrinsic defect of vascular MCs in supporting angiogenic
capillary structures. The CADASIL MCs could either
directly interfere with the stability of the capillary struc-
tures formed by ECs, or decrease the secretion of paracrine
factors such as VEGF to reduce the tubule stability. This
mechanism likely delays the brain tissue repair after stroke
in CADASIL patients and contributes to the reduced capil-
lary density and cerebral hypoperfusion in CADASIL brains
reported in recent studies (Joutel et al., 2010), and could
explain the endothelial phenotype reported in CADASIL
arteries.
CADASIL is a typical dominant single-gene disorder. To
date, more than 200 different mutations in the NOTCH3
gene have been documented in the HumanGeneMutation
Database, the majority of which are missense mutations.
Although there is no significant genotype-phenotype
correlation in the clinical cases and disease severity varies
among members from the same family, mutations in
the NOTCH3 gene are highly stereotypical. Almost all
CADASIL mutations fall within the EGF repeats of the
extracellular domain of the NOTCH3 protein, which gives
rise to loss or gain of a cysteine amino acid resulting in odd
numbers of cysteines in a given EGF repeat (Joutel et al.,
1997). As a result, CADASIL pathologies in the vasculature
are unique and consistent across the spectrum of different
mutations. Additionally, about 70% of all CADASIL muta-
tions are clustered in exons 3 and 4 of the NOTCH3 gene
(Joutel et al., 1997), suggesting the importance of the N-ter-
minal region of the protein in disease pathology. The iPSCs
used in our study were generated from two CADASIL pa-
tients carrying mutations Arg153Cys and Cys224Tyr,
respectively. Both mutations locate within exon 4 of
the NOTCH3 gene, with one mutation creating gain of
a cysteine residue (Arg153Cys) and the other loss of a
cysteine (Cys224Tyr). These are representative of common
CADASIL mutations. The two CADASIL patients also had
Figure 5. Effect of iPSC-MC-Secreted Soluble Factors on iPSC-EC Angiogenesis
(A) Images of in vitro iPSC-EC angiogenesis assay in the presence of conditioned medium from CADASIL or control iPSC-MCs for 24 h. Scale
bars, 100 mm.
(B) Quantification of total network length of iPSC-EC in vitro angiogenesis assays when cultured with conditioned media from CADASIL or
control iPSC-MCs 24 h after cell seeding.
(C) In vitro angiogenesis assay in a transwell setup of iPSC-EC/MC co-culture where iPSC-ECs were cultured on the bottom of the well and
iPSC-MCs on the surface of the insert, as shown by the diagram on the right.
Data in (B) and (C) are presented as mean ± SEM of three independent experiments (n = 3). Each experiment contained samples from three
clones of each CADASIL or three clones of control lines. One-way (B) or two-way (C) ANOVA with Tukey’s post hoc test, ***p% 0.001 versus
controls.
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cognitive decline, which represent the common pheno-
types of the CADASIL cohort.
In our study, the ‘‘footprint-free’’ reprogramming with
SeVwas used, which has avoided post-transfection genome
perturbation, making the iPSC disease model more physio-
logical. One of the two control iPSC lines was from thesibling of one patient, which has minimized the genetic
background variation. Most importantly, key findings
from CADASIL iPSCs were recapitulated in primary VSMCs
isolated from small arteries of skin biopsies of CADASIL pa-
tients (Figures S4, 4C, and 6D). However, with respect to
the control primary VSMCs, due to the limited availability
of the skin biopsy, we have used primary human coronaryStem Cell Reports j Vol. 13 j 1–15 j November 12, 2019 9
Figure 6. Identification of Abnormal
Paracrine Factors Secreted from the CA-
DASIL iPSC-MCs
(A) Angiogenesis Proteome Profiler Array
(R&D Systems) was screened using condi-
tioned media from CADASIL and control
iPSC-MCs. VEGF (red circles) was identified
as downregulated (blue arrows) in condi-
tioned media of CADASIL iPSC-MCs.
(B) ELISA quantitation of VEGF in the
conditioned media of iPSC-MCs.
(C) qRT-PCR quantitation of VEGF in iPSC-
MCs. Data in (B) and (C) are mean ± SEM of
three independent experiments (n = 3).
Each experiment contained samples from
three clones of each CADASIL or three clones
of each control line.
(D) VEGF secretion from primary SMCs
isolated from a CADASIL patient. Equal
numbers of primary SMCs from small arteries
of CADASIL patients and healthy human
coronary arteries (hCASMCs, control) were
seeded in serum-free medium for 3 days.
VEGF-165 levels in the conditioned medium
were measured by ELISA assay and normal-
ized to the final cell numbers in each well.
Data are mean ± SEM from three indepen-
dent experiments. Unpaired Student’s t test,
***p% 0.001.
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from small vessels (coronary arteries) of healthy individuals
for some of the experiments (Figures S4 and 6D). As small
arteries rather than large conduit arteries are typically
involved in CADASIL, we consider that the hCASMCs
from ‘‘normal’’ subjects (i.e., without CADASIL and
NOTCH3 mutations) are appropriate as control human
non-CADASIL cells. Nevertheless, in future work we hope
to entirely eliminate the influence of genetic background
by introducing isogenic control iPSC lines.
Based on knowledge of endothelial differentiation dur-
ing embryonic development, we optimized a chemically
defined highly reproducible protocol for EC differentia-
tion. This protocol gave >40% differentiation efficiency,
from which pure populations of ECs were obtained by
VE-cadherin cell sorting. This EC differentiation protocol
was not designed to generate brain-specific microvascular
endothelial cells that possess barrier functions. Given the
fact that barrier genesis in the brain is a process that follows
the primary angiogenic vascular network formation, the
iPSC-ECs used in our study likely reflect an early general10 Stem Cell Reports j Vol. 13 j 1–15 j November 12, 2019angiogenesis process. For MC differentiation, we adopted
a neuroectoderm-specific VSMC differentiation protocol
described by Cheung et al. (2012). The wild-type iPSC-
MCs obtained in our study exhibited a typical pericyte
function in supporting EC capillary structures. Pericytes
and VSMCs are vascular MCs, with the former specifically
located directly on the capillary wall and the latter sitting
in the middle layer of muscular vessels and arterioles.
Both cell types originate from either mesoderm or neural
crest (neuroectoderm) during embryonic development
and share marker genes, making them difficult to distin-
guish without functional assays (Winkler et al., 2011).
However, a more recent study using single-cell RNA
sequencing on mouse brain vasculature (Vanlandewijck
et al., 2018) demonstrated that PDGFRb and NG2 were ex-
pressed in both SMCs andpericytes, whereas a-SMA,CNN1,
and SM22 were only expressed in SMCs and not in peri-
cytes. On the other hand, recent publications have also
noticed that when pericytes, including human primary
pericytes, were put in cell culture, they consistently ex-
pressed a-SMA (Alarcon-Martinez et al., 2018; Smyth
Figure 7. Phenotype Rescue of the Defec-
tive iPSC-EC/MC Tubule Stability by Exog-
enous VEGF or siRNA Knockdown of
NOTCH3 in iPSC-MCs
(A) In vitro angiogenic tubule formation by
co-culture of iPSC-ECs/MCs on Matrigel was
carried out in the presence or absence of
20 ng/mL recombinant VEGF-165.
(B) In vitro angiogenic tubule formation was
carried out by co-culture of iPCS-ECs/MCs
with NOTCH3 knocked down in iPSC-MCs by
siRNA.
(C) Confirmation of siRNA knockdown of
NOTCH3 by western blotting (i). The quan-
tification of the western blotting results is
shown in (ii). Data are integrated density
relative to the protein loading control
vimentin, and presented as mean ± SEM.
Shown are example results from one of the
iPSC clones and three independent siRNA
knockdown samples. Student’s t test, ***p
% 0.001.
(D) VEGF was quantified in the conditioned
medium from CADASIL or control iPSC-MCs
after siRNA NOTCH3 knockdown.
Data are presented as mean ± SEM of three
independent experiments (n = 3). Each
experiment contained samples from three
clones of each CADASIL or three clones of
each control line. Two-way ANOVA and
Turkey’s post hoc test, ***p% 0.001 versus
non-treated samples (A and B), or versus
control samples (D). Scrambled was the
control siRNA.
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explanations include the culture conditions, e.g., the use
of serum (Rustenhoven et al., 2016; Tigges et al., 2012),
proliferation status (Rustenhoven et al., 2016), the lack of
laminin (Yao et al., 2014), or the detection method (Alar-
con-Martinez et al., 2018). Three contractile markers,
a-SMA, CNN1, and SM22a, were found to be expressed inhuman primary pericytes (Stebbins et al., 2019). It seems
that the expressions of a-SMA, CNN1, and SM22a seen un-
der in vitro cell-culture conditions do not necessarily rule
out the pericyte-like nature of the iPSC-derived MCs. Of
prime importance is that the cells recapitulate key func-
tional attributes of pericytes. The iPSC-MCs in our study
expressed key pericyte markers, PDGFRb and NG2, inStem Cell Reports j Vol. 13 j 1–15 j November 12, 2019 11
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that they represent an in vitro pericyte-like model that
can be used for angiogenesis assays independent of a
VSMC model. The iPSC-MCs derived via the neuroecto-
derm lineage were more closely representative of MCs in
the cerebral vasculature, where the CADASIL pathology
mainly resides, than iPSC-MCs differentiated via a meso-
dermal lineage (data not shown).
During angiogenesis, pericytes are recruited via cell-sur-
face receptor PDGFRb to the nascent capillary tubule by
the soluble ligand PDGF-BB secreted locally from the tip
of endothelial sprouts. This, together with other regula-
tors such as ANG1-TIE2 signaling, supports the capillary
stability (Phng and Gerhardt, 2009; Ribatti et al., 2011).
Such function is more likely perturbed due to the loss of
PDGFRb in the CADASIL iPSC-MCs, although we did
not directly demonstrate this process. This is supported
by a recent publication based on PDGFRb immunostain-
ing where reduction of pericyte numbers was observed
in a CADASIL transgenic mouse model (Ghosh et al.,
2015). We did not find any change in TIE2 expression
in the CADASIL MCs, suggesting that ANG1-TIE2
signaling is unlikely involved in the impaired capillary
structural stability in CADASIL. NOTCH3 is important
for the establishment of brain vascular integrity by regu-
lating pericyte numbers and for the investment of MCs
in angiogenesis (Henshall et al., 2015; Wang et al.,
2014). Such a function is likely perturbed by the NOTCH3
mutations in CADASIL.
In the central nervous system, pericytes also play a cen-
tral role in the regulation of capillary diameter, which con-
trols pressure-induced autoregulation of cerebral blood
flow (CBF) (Winkler et al., 2011). Reduced CBF has already
been observed in CADASIL patients, and pressure-induced
regulation of myogenic tone was found to be impaired in
a CADASIL mouse model (Hussain et al., 2004; Lacombe
et al., 2005). Evidence from the mouse model also sug-
gested that brain capillary rarefaction contributes to CBF
reduction (Joutel et al., 2010). Therefore, dysfunction of
pericyte-like cells found in our study could likely be a key
mechanism contributing to the cerebral vascular pheno-
type in CADASIL individuals.
VEGF is a critical factor that drives and guides angiogen-
esis (Herbert and Stainier, 2011). VEGF secreted by peri-
cytes also acts in a juxtacrine/paracrine manner as a
survival and stabilizing factor for ECs in microvessels
(Darland et al., 2003). A recent study demonstrated that
VEGF enhanced pericyte coverage of brain ECs via mech-
anisms involving increased N-cadherin expression on ce-
rebral microvessels (Zechariah et al., 2013). It is therefore
not difficult to understand the impaired stabilization of
the capillary structures by the CADASIL iPSC-MCs with
reduced secretion of VEGF in our study. Once MCs are12 Stem Cell Reports j Vol. 13 j 1–15 j November 12, 2019recruited to the angiogenic stalks, VEGF levels are locally
reduced to support the establishment of quiescence of the
capillary structure. Excess VEGF at this stage could pro-
mote EC migration, leading to tubule instability. This
could partially explain the incomplete rescue of the
angiogenic phenotype by supplementing VEGF in this
study, in addition to the impaired direct interactions be-
tween CADASIL MCs and ECs. While we have focused
on VEGF in the present study, data from the angiogenesis
proteome profiler arrays screen suggest that many other
factors may also be important and warrant further
investigation.
It is known that CADASIL NOTCH3 mutations do not
usually disrupt the RBP-Jk-mediated canonical Notch
signaling, since in Notch3/ mice crossed with CADASIL
transgenic mice, activation of RBP-Jkwas restored, suggest-
ing that CADASILNOTCH3mutations are not loss-of-func-
tion mutations (Monet et al., 2007). However, it is not
known whether the mutations lead to loss of an as yet un-
identified NOTCH3 function, which has not been investi-
gated due to limitations of the existing models. Using
siRNA knockdown of NOTCH3 in the CADASIL iPSC-
derived MCs, the phenotype of impaired angiogenic tu-
bule stability was significantly rescued to a similar extent
as when VEGF was supplemented (Figures 7A and 7B).
This was accompanied with a full restoration of VEGF
secretion (Figure 7D), suggesting a gain-of-function mech-
anism. The nature of the neomorphic function awaits
further investigation but is unlikely through the activation
of the canonical Notch signaling, as neither NOTCH3
expression nor its target genes were changed in the
CADASIL iPSC-MCs (Figure S3). Furthermore, knockdown
of NOTCH3 in the control MCs did not give rise to the
same angiogenic phenotype seen in CADASIL MCs, con-
firming that the impaired angiogenic tubule stability was
not via a loss-of-function mechanism through the mutant
NOTCH3.
In conclusion, we have established a patient-specific
iPSC model for CADASIL, the most common type of ge-
netic stroke and vascular dementia syndrome. The iPSCs
were successfully differentiated into ECs and MCs. Func-
tional characterizations of the iPSC-derived vascular cells
revealed significant failure of the CADASIL MCs to support
angiogenic capillary structures, maintain EC survival, and
secrete angiogenic paracrine factors. Key findings from
the iPSCmodel were also confirmed in primary VSMCs iso-
lated from CADASIL patients. The novel mechanisms we
have identified will help to unravel the contribution of
vascular factors to cerebral pathologies in CADASIL and
related diseases and identify drug targets. The phenotype
and the iPSC model could be used for high-throughput
screening of potential therapeutic molecules for future
treatment of CADASIL.
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Please see Supplemental Information for details of the methods.Establishment of Patient-Derived iPSCs
Dermal fibroblasts were isolated from skin biopsies of two
CADASIL patients carrying NOTCH3 Arg153Cys and Cys224Tyr
mutations, respectively, and a non-affected control individual un-
der a local ethical approval (REC reference no. 12/NW/0533). Adult
HDFs were purchased from Invitrogen as an additional non-
CADASIL control. The HDFs were reprogrammed into iPSCs using
the Cytotune-iPSC 2.0 kit (Life Technologies) according to the
manufacturer’s instructions. Twenty-eight days after the SeV-medi-
ated delivery of OCT, SOX-2, KLF4, and C-MYC, positive iPSC col-
onies were identified, excised, and cultured in Essential 8 medium
(E8; Life Technologies) on vitronectin (VTN-N)-coated (Life Tech-
nologies) 6-well plates. Selected iPSC clones were karyotyped and
NOTCH3mutations were confirmed by Sanger DNA sequencing.Endothelial Cell Differentiation from iPSCs
iPSCswere seededontoaVTN-N-coated6-well plate at around1 cell
cluster (10–20 cells) per cm2 and cultured for 24h at 37C inE8 con-
taining 10 mM Y-27632 followed by a further 24-h culture without
Y-27632. The cells were then cultured in Essential 6 medium (E6;
Life Technologies) supplemented with 3 mM CHIR99021 (Calbio-
chem), 10 ng/mL recombinant BMP4 (Peprotech), and 10 ng/mL
recombinant FGF2 (Peprotech). After a further 24 h of culture,
the medium was replaced with E6 supplemented with 50 ng/mL
BMP4and10ng/mLFGF2, and renewed every 24h.Onday7of dif-
ferentiation, BMP was reduced to 25 ng/mL, and 25 ng/mLVEGF-
165 (Peprotech) was included in the medium. The cells were
cultured for a further 24 h before VEGF-165 was increased to
50 ng/mL and BMP4 was withdrawn. The medium was replaced
every 24 h until day 12 of differentiation. A pure population of
iPSC-ECs was then obtained by fluorescence-activated cell sorting
usingPE-conjugatedhumanVE-cadherin antibody (R&DSystems).Mural Cell Differentiation from iPSCs
MC differentiation via a neuroectoderm lineage was adapted from
Cheung et al. (2012). In brief, iPSCs were seeded on VTN-N-coated
6-well plates at around 1–2 clusters/cm2 in E8 supplemented with
10 mMof Y-27632 and cultured for 24 h before switching to E6 that
contained 10 mM SB-431542 (Sigma-Aldrich) and 10 ng/mL FGF2.
The mediumwas replaced every 24 h until day 6 when the supple-
ments were replacedwith 2 ng/mLTGF-b (Peprotech) and 5 ng/mL
PDGF-BB (Peprotech). The medium was refreshed every 24 h until
day 18 of differentiation.Primary Culture Vascular Smooth Muscle Cells from
Patients with CADASIL
To validate our findings in iPSCs, we conducted some experi-
ments, particularly angiogenesis and apoptosis experiments, in
primary cultured VSMCs from clinically phenotyped patients
with CADASIL. Cells from four CADASIL patients (mutations
Arg169Cys, Arg141Cys, and Arg54Cys) and four controls were
used between passages 2 and 6.Reverse-Transcription qPCR
Total RNA was extracted from cells using the RNeasy mini kit
(Qiagen) according to the manufacturer’s instructions and reverse
transcribed to cDNA using a Tetro cDNA synthesis kit (Bioline).
Standard qPCR was carried out using SYBR Green reagent (Applied
Biosystems; Thermo Scientific). All samples were analyzed in
triplicate.
Immunofluorescence Staining and Western Blotting
Immunofluorescence staining and western blotting were per-
formed as described previously (Wang et al., 2007).
Angiogenesis Assay
Ten thousand iPSC-derived iPSC-ECs or a mixture of 13 104 iPSC-
ECs and 0.5 3 104 iPSC-MCs were plated onto a thin layer of
Matrigel in 96-well plates in E6 supplemented with 5 ng/mL
VEGF-165 and 2 ng/mL FGF2, and cultured in a CO2 incubator
at 37C for 3, 6, 12, 24, 48, and 72 h, respectively, for capillary
network formation. Results were quantified using ImageJ software.
The in vivo angiogenesis assay was performed according to proto-
cols approved by the Institutional Committee for Use and Care of
Laboratory Animals (Kings College, London). One hundredmicro-
liters containing differentiated iPSC-MCs and iPSC-ECs (1 3 106
cells per sample) was injected subcutaneously into the back or
flank of NOD.CB17-Prkdcscid/NcrCrl mice. Six injections were
conducted for each group. Fourteen days later, the Matrigel plugs
were harvested, frozen in liquid nitrogen, and cryosectioned for
immunostaining.
Angiogenesis Proteome Profiler Array Analysis and
ELISA
The Proteome Profiler Human Angiogenesis Array Kit (ARY007,
R&D Systems) was used to screen angiogenesis-related proteins
secreted from the control and CADASIL iPSC-MCs in the condi-
tioned medium according to the manufacturer’s protocol. Re-
sults were confirmed by ELISA assays using a Human VEGF
Quantikine ELISA kit (R&D Systems). All samples were analyzed
in triplicate.
Apoptosis Assay
The apoptosis of iPSC-MCs and iPSC-ECs was measured using the
Caspase-Glo 3/7 Assay kit (Promega). All samples were analyzed in
triplicate.
Nitric Oxide Measurement
Nitric oxide concentration in the cell-culture mediumwas quanti-
fied using the Griess Reagent System (Promega). All samples were
analyzed in duplicate.
Small Interfering RNA NOTCH3 Knockdown in iPSC-
MCs
Notch3-specific siRNA sequences and a scrambled negative control
siRNA were purchased from Qiagen (Venlo, Netherlands) and
delivered to iPSC-MCs by the 4D-nucleofector system (AAF-
1002B+ X unit) (Lonza) using the 4D p3 kit (Lonza) with program
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Gaussian distribution of each dataset was determined by the Sha-
piro-Wilks test. Data were presented as mean ± SEM. The unpaired
Student’s t test was used to compare differences between results
from two groups of samples. Where more than two means were
compared, one-way or two-way ANOVA in conjunction with Tu-
key’s post hoc test or Bonferroni’s post hoc test were performed.
A p value of%0.05 was considered statistically significant.
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